Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...6, 7, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-05-02
8:23 pm
Purchase
13GVallon Pharmaceuticals, Inc.
VLON
Altium Capital Management LP1,269,210
9.99%
1,269,210increase
(New Position)
View
2023-04-26
5:18 pm
Purchase
13GMarpai, Inc.
MRAI
Altium Capital Management LP1,805,327
6.2%
1,805,327increase
(New Position)
View
2023-02-14
4:51 pm
Unchanged
13GXtant Medical Holdings, Inc.
XTNT
Altium Capital Management LP6,497,918
5.7%
0
(Unchanged)
View
2023-02-14
3:59 pm
Unchanged
13GAstria Therapeutics, Inc.
ATXS
Altium Capital Management LP1,355,372
4.95%
0
(Unchanged)
View
2023-02-14
2:44 pm
Sale
13GHyreCar Inc.
HYRE
Altium Capital Management LP1,688,120
5.6%
-48,795decrease
(-2.81%)
View
2023-02-14
2:35 pm
Unchanged
13GMuscle Maker, Inc.
GRIL
Altium Capital Management LP2,888,085
4.99%
0
(Unchanged)
View
2023-02-14
12:35 pm
Sale
13GNeuroBo Pharmaceuticals, Inc.
NRBO
Altium Capital Management LP0
0%
-333,333decrease
(Position Closed)
View
2023-02-14
12:26 pm
Sale
13GPalisade Bio, Inc.
PALI
Altium Capital Management LP0
0%
-3,350,000decrease
(Position Closed)
View
2022-12-21
2:12 pm
Purchase
13GAstria Therapeutics, Inc.
ATXS
Altium Capital Management LP1,355,372
5.2%
1,355,372increase
(New Position)
View
2022-11-17
5:08 pm
Purchase
13GNeuroBo Pharmaceuticals, Inc.
NRBO
Altium Capital Management LP333,333
7.7%
333,333increase
(New Position)
View
2022-11-08
7:44 pm
Purchase
13GHyreCar Inc.
HYRE
Altium Capital Management LP1,736,915
5.8%
1,736,915increase
(New Position)
View
2022-02-14
3:09 pm
Sale
13GPalisade Bio, Inc.
PALI
Altium Capital Management LP3,350,000
9.99%
-644,302decrease
(-16.13%)
View
2022-02-14
3:06 pm
Purchase
13GQuoin Pharmaceuticals, Ltd.
QNRX
Altium Capital Management LP4,276,252
4.99%
3,037,823increase
(+245.30%)
View
2022-02-14
2:37 pm
Purchase
13GPalisade Bio, Inc.
PALI
Altium Capital Management LP3,994,302
4.99%
2,668,410increase
(+201.25%)
View
2022-02-14
2:30 pm
Sale
13GRegulus Therapeutics Inc.
RGLS
Altium Capital Management LP1,729,780
2.1%
-1,500,000decrease
(-46.44%)
View
2022-02-14
10:16 am
Unchanged
13Gurban-gro, Inc.
UGRO
Altium Capital Management LP0
0%
0
(Unchanged)
View
2022-02-14
09:53 am
Unchanged
13GOcuphire Pharma, Inc.
OCUP
Altium Capital Management LP2,678,883
4.99%
0
(Unchanged)
View
2022-02-14
09:40 am
Sale
13GTimber Pharmaceuticals, Inc.
TMBR
Altium Capital Management LP5,878,414
4.99%
-3,000,000decrease
(-33.79%)
View
2022-02-14
06:16 am
Sale
13GelectroCore, Inc.
ECOR
Altium Capital Management LP0
0%
-5,000,000decrease
(Position Closed)
View
2022-02-14
06:11 am
Purchase
13GUnicycive Therapeutics, Inc.
UNCY
Altium Capital Management LP176,000
1.2%
176,000increase
(New Position)
View
Goto 0, 1, 2, ...6, 7, Next